Cellino Company

Cellino is on a mission to make personalized, autologous cell therapies accessible for patients.
Technology: Cell-based gene therapy
Industry: Private
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2017-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 7
Total Funding: 97500002
Estimated Revenue: Less than $1M
Last Funding Date: 2022-01-25
Last Funding Type: Series A

Visit Website
info@cellinobio.com
https://twitter.com/cellinobio
Register and Claim Ownership